
Pulled from Benzinga Pro data, Organogenesis Holdings (NASDAQ:ORGO) posted Q1 earnings of $87.00 thousand, an increase from Q4 of 99.83%. Sales dropped to $98.12 million, a 23.68% decrease between quarters. In Q4, Organogenesis Holdings earned $51.70 million and total sales reached $128.56 million.